Hybrid/Decentralized Clinical Trial (DCT) Master Class:

Equip your sponsor and Biotech studies for digital success in 2022

Limited time only. Save your spot today!
February 24th, 2022 | 11AM PST
Registration cut off: February 21st, 2022

Do you want to become an expert in hybrid and decentralized clinical trial design?

Are you ready to learn how to uncover what Tuft’s describes as a possible “net benefit of up to 5x the upfront investment required in phase II studies, and up to 13x greater in phase III?”

For a limited time only, Medable is offering a free Certification in Decentralized Clinical Trial (DCT) through our Master Class.

In this class, Medable Senior Vice President of Partnerships, Jared Klingeisen and Senior Business Director, Nancy Sack will discuss the emergence of the DCT market and best practices for implementing digital strategies on your next study. Clinical teams will gain valuable knowledge and strategies to improve patient enrollment, engagement and retention and reduce overall delivery timelines and costs. In taking the DCT Master Class, you will gain:

  • A strong foundation of knowledge of hybrid and decentralized trials
  • The ability to convey key elements and best practices in implementing Decentralized Trials for customers
  • An understanding of how Decentralized Clinical Trials operate at both the site and patient levels
  • A DCT certification badge to profile your social media accounts (i.e. LinkedIn, Twitter) and email signature

Don’t miss out on this limited time opportunity to learn from the No. 1 DCT provider in the industry!

February 24th, 2022 | 11AM PST - Limited time only. Save your spot today! Cut off date to register - February 21st, 2022

Jared Klingeisen is Senior Vice President of Partner DCT Enablement Strategy.

Nancy Sack is responsible for business development activities at Medable.

Save the Date!